Pfizer and BioNTech to seek approval of booster dose for those aged 16 to 17
Health
- 30 November, 2021
- 05:20
Pfizer and BioNTech are expected to seek authorization this week for a Covid-19 vaccine booster for teens 16 and 17 years old, Report informs, citing foreign media.
If approved, the additional Pfizer-BioNTech shot would mark the first vaccine booster for teens younger than 18.
The move comes as a new variant of coronavirus, known as omicron, spreads around the globe, worrying experts and pushing President Joe Biden to urge caution and again implore Americans to get inoculated.
Latest News
20:20
President of Azerbaijan: For us, Italian market is of primary importance for both oil and gas
Foreign policy20:15
President Ilham Aliyev and President of Council of Ministers of Italy deliver press statements
Foreign policy20:07
President: Italy is Azerbaijan's number one trading partner
Foreign policy20:00
President Ilham Aliyev: Azerbaijan and Italy are strategic partners
Foreign policy19:59
Costa: EU deepens cooperation with Armenia, to continue supporting Ukraine
Other countries19:51
Photo
President Ilham Aliyev held expanded meeting with President of Italian Council of Ministers
Foreign policy19:47
Georgia, Türkiye expand economic cooperation
Region19:39
Costa: Ilham Aliyev's participation added further significance to EPC summit in Yerevan
Region19:32
Photo